Neogen (NEOG) EBIT Growth (1y) (2011 - 2026)
Neogen (NEOG) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 16.18% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 100.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 100.51% |
| Feb 28, 2026 | -161.11% |
| Nov 30, 2025 | 98.82% |
| Aug 31, 2025 | -812.94% |
| May 31, 2025 | -4,787.09% |
| Feb 28, 2025 | -55.09% |
| Nov 30, 2024 | -3,262.70% |
| Aug 31, 2024 | -88.20% |
| May 31, 2024 | -44.33% |
| Feb 29, 2024 | -23.34% |
| Nov 30, 2023 | 288.94% |
| Aug 31, 2023 | 215.65% |
| May 31, 2023 | 29.94% |
| Feb 28, 2023 | 145.95% |
| Nov 30, 2022 | -161.40% |
| Aug 31, 2022 | -72.12% |
| May 31, 2022 | -11.00% |
| Feb 28, 2022 | -59.57% |
| Nov 30, 2021 | -35.21% |
| Aug 31, 2021 | 1,208.87% |